Heterologous expression of NRPS and PKS pathways in Escherichia coli : from bottlenecks to biosynthetic platforms
Essays in Biochemistry · 2026
DOI: 10.1042/ebc20250044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Essays in Biochemistry, 2026. Verfasst von Lisa Göbner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Natural Product Biotechnology, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Helmholtz Centre for Infection Resea…. Hauptthemen laut MEDLINE: Escherichia coli, Peptide Synthases, Polyketide Synthases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hans Fischer Society.
Abstract (Originalsprache)
Microbial natural products (NPs) represent one of the most important sources of bioactive compounds in medicine, agriculture, and biotechnology. Non-ribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs) are large multidomain complexes that enable the efficient generation of highly diverse and complex NPs. Advances in genome sequencing and bioinformatics have revealed an enormous and largely untapped biosynthetic potential encoded in microbial genomes. However, the majority of NPs remain inaccessible due to a lack of genetic tools, silent biosynthetic gene clusters (BGCs) or the inability to culture the vast majority of microbes. Heterologous expression has therefore emerged as a key strategy to access and engineer NPs. Among available expression platforms, Escherichia coli is a pivotal host due to its rapid growth, genetic tractability, and unparalleled molecular toolbox. This review focuses on heterologous expression of NRPS/PKS pathways in E. coli, with particular emphasis on experimental optimisation strategies. Drawing on selected case studies, we highlight how systematic approaches—such as promoter refactoring, expression-rate tuning, chaperone or helper protein co-expression, metabolic engineering, precursor feeding, and cultivation optimisation—can transform initially unsuccessful systems into productive expression platforms. Collectively, these examples illustrate that apparent limitations in E. coli are engineering challenges rather than intrinsic barriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Natural Product Biotechnology, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Helmholtz Centre for Infection Research (HZI), Campus E8.1, 66123 Saarbrücken, Germany.
- Department of Pharmacy and PharmaScienceHub (PSH), Saarland University, Campus E8.1, 66123 Saarbrücken, Germany.
- Chair of Technical Biochemistry, Technical University of Dresden, Bergstr. 66, 01069 Dresden, Germany.
ORCID-Profile: Lisa Göbner, Tobias A M Gulder, Paul M D'Agostino
Förderung
- Hans Fischer Society
Zitieren
APA
Göbner, L., Gulder, T. A. M., & D'Agostino, P. M. (2026). Heterologous expression of NRPS and PKS pathways in Escherichia coli : from bottlenecks to biosynthetic platforms. Essays in Biochemistry. https://doi.org/10.1042/ebc20250044
Vancouver
Göbner L, Gulder TAM, D'Agostino PM. Heterologous expression of NRPS and PKS pathways in Escherichia coli : from bottlenecks to biosynthetic platforms. Essays in Biochemistry. 2026. doi:10.1042/ebc20250044
BibTeX
@article{Gbner2026,
author = {Göbner, Lisa and Gulder, Tobias A M and D'Agostino, Paul M},
title = {Heterologous expression of NRPS and PKS pathways in Escherichia coli : from bottlenecks to biosynthetic platforms},
journal = {Essays in Biochemistry},
year = {2026},
doi = {10.1042/ebc20250044}
}
EUVIMED